Reduction of systemic inflammation by elexacaftor/tezacaftor/ivacaftor correlates with lung function improvement in cystic fibrosisOlga Halle, Anna‐Maria Dittrich, Azadeh Bagheri-Pothoff et al.|European Respiratory Journal|2025Cited by 12
Breath volatile organic compounds and inflammatory markers in adult asthma patients: negative results from the ALLIANCE cohortOlaf Holz, Thomas Bahmer, Benjamin Waschki et al.|European Respiratory Journal|2020Cited by 12
Validation of the Asthma Severity Scoring System (ASSESS) in the ALLIANCE CohortRuth Grychtol, Lennart Riemann, Svenja Gaedcke et al.|Journal of Allergy and Clinical Immunology|2023Cited by 6
Exploring trends and predictors of long-term asthma remissionVera Veith, Mustafa Abdo, Frauke Pedersen et al.|World Allergy Organization Journal|2025Cited by 3
Additional file 1 of Increased high sensitivity C-reactive protein in more severe wheeze/asthma phenotypes in child- and adulthood in ALLIANCELena Lagally, Bianca Schaub, Lena Ullemeyer et al.|Figshare|2026Cited by 0